Education
About Us
Working with TipRanks
Follow Us
GRI Bio (GRI)
NASDAQ:GRI
Total Valuation
GRI Bio has a market cap or net worth of $3.24M. The enterprise value is -$1.67M.
Market Cap$3.24M
Enterprise Value-$1.67M
Share Statistics
GRI Bio has 2,347,272 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,347,272
Owned by Insiders26.75%
Owned by Institutions0.34%
Financial Efficiency
GRI Bio’s return on equity (ROE) is -2.04 and return on invested capital (ROIC) is -200.71%.
Return on Equity (ROE)-2.04
Return on Assets (ROA)-1.43
Return on Invested Capital (ROIC)-200.71%
Return on Capital Employed (ROCE)-2.01
Revenue Per Employee0.00
Profits Per Employee-2.74M
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of GRI Bio is -0.31. GRI Bio’s PEG ratio is >-0.01.
PE Ratio-0.31
PS Ratio0.00
PB Ratio0.06
Price to Fair Value0.64
Price to FCF-0.38
Price to Operating Cash Flow-0.03
PEG Ratio>-0.01
Income Statement
In the last 12 months, GRI Bio had revenue of 0.00 and earned -8.21M in profits. Earnings per share was -55.21.
Revenue0.00
Gross Profit0.00
Operating Income-8.23M
Pretax Income-8.21M
Net Income-8.21M
EBITDA-8.23M
Earnings Per Share (EPS)-55.21
Cash Flow
In the last 12 months, operating cash flow was -12.17M and capital expenditures 0.00, giving a free cash flow of -12.17M billion.
Operating Cash Flow-12.17M
Free Cash Flow-12.17M
Free Cash Flow per Share-5.19
Dividends & Yields
GRI Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.75
52-Week Price Change-97.64%
50-Day Moving Average1.71
200-Day Moving Average8.19
Relative Strength Index (RSI)39.91
Average Volume (3m)333.55K
Important Dates
GRI Bio upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date―
Financial Position
GRI Bio as a current ratio of 3.43, with Debt / Equity ratio of 2.95%
Current Ratio3.43
Quick Ratio3.43
Debt to Market Cap0.00
Net Debt to EBITDA0.60
Interest Coverage Ratio0.00
Taxes
In the past 12 months, GRI Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
GRI Bio EV to EBITDA ratio is 0.28, with an EV/FCF ratio of 0.27.
EV to Sales0.00
EV to EBITDA0.28
EV to Free Cash Flow0.27
EV to Operating Cash Flow0.27
Balance Sheet
GRI Bio has $4.75M in cash and marketable securities with $131.00K in debt, giving a net cash position of -$4.62M billion.
Cash & Marketable Securities$4.75M
Total Debt$131.00K
Net Cash-$4.62M
Net Cash Per Share-$1.97
Tangible Book Value Per Share$22.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for GRI Bio is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside624.64% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast98.55%